Category: <span>Conferences</span>
Registrations are now open for the virtual 2021 ACTA Annual Scientific Meeting!
Bellberry is delighted to once again sponsor the ACTA Annual Scientific Meeting. This year’s meeting will focus on Strengthening the pipeline for clinical trials. At a time when the spotlight is firmly on clinical trials across the globe, there has never been a more critical time for our sector’s leaders and consumers to come together to share knowledge, experiences, challenges, and opportunities for change.
The 3-day event will be held online from 10 – 12 November 2021. Further details can be found on the ACTA ASM website.
The Academy’s 2021 Annual Scientific Meeting will be delivered online over two half days, where invited international and national presenters will explore and discuss ‘The impact of research’.
Click here for the full event program
Join Bellberry throughout AusBiotech 2021. The week includes:
-
A week of interactive online programming, accessible live and on-demand for a further 30 days
-
International and national keynote speakers
-
Expert panel discussions
-
The AusBiotech and Johnson & Johnson Innovation Industry Excellence Awards 2021
-
A week of virtual AusPartnering, AusBiotech’s business matching programme
-
Networking lounge to engage, make new contacts, and exchange thoughts in randomly-allocated virtual rooms
-
Early-Stage Investment Forum
-
Opportunity to connect with industry through our BioIndustry Company Profile platform
-
MORE VALUE ADDED: Access to Australia’s preeminent life science investment event Australia Biotech Invest & Partnering 2021.
This month the White Coats Foundation are launching a two-part webinar series titled ‘De-Mystifying Consumer and Community Involvement in Research.‘
The White Coats Foundation looks at “de-mystifying” consumer and community involvement in research via a two-part webinar series that aims to:
- Provide clarification on what “consumer and community involvement” in research means.
- Provide insight into the training options available to support consumers with basic skills and knowledge to effectively engage in research.
- Explore the barriers to consumer engagement.
- Explore pathways that can facilitate the connection between researchers and consumers. These avenues are underdeveloped and need to be reviewed.
- Explore feedback mechanisms to consumers on outcomes of involvement and ensure participation is value-adding.
The two sessions will be held on Weds 15 and Weds 22 September.
The ARCS conference earlier this month was a resounding success. Bellberry representatives Alison Barr (Quality Manager), Chloe Shard (Team Leader), Reuben Jacobs (Manager for Business and Strategic Projects) and Jerneen Williams (EPCT Manager) all attended and ‘manned’ the Bellberry booth. They were delighted to meet so many new faces and talk about our HRECs and also catch up with so many familiar faces!
CT:IQ also attended the conference and CT:IQ’s Programme Director, Leanne Weekes said “It was a wonderful opportunity to share information about our projects to everyone who stopped by the CT:IQ booth”. Leanne was part of a panel session discussing, ‘How eConsent is being used in Australia to support clinical trials’.
The ARCS conference was particularly special for Bellberry this year as our CEO Kylie Sproston was awarded the 2021 ARCS MTP Sector Awards Innovation award! Many congratulations to Kylie and the whole BellBerry team on this wonderful achievement.
Join experts from Austrade, Baker McKenzie, Bellberry and IQVIA in a discussion on conducting clinical trials in Australia. This one hour webinar will explore:
- the benefits of conducting clinical trials in Australia for US companies
- the steps in the clinical trial process
- due diligence issues to consider
- how to apply for an Australian R&D tax incentive.
There will also be an opportunity for questions. Bellberry CEO Kylie Sproston will be part of this discussion.
Click here to register!
Join us in Sydney next week for the ARCS 2021 annual conference.
The conference is renowned for being the must-attend conference for the pharmaceutical and medical technology industries. It brings together decision-makers as well as a broad cross-section of people working in industry, government and the university sectors. The conference will provide a unique opportunity for those attending to participate in plenary sessions, workshops and round tables. Sessions will be of relevance to professionals involved in regulatory affairs, clinical research, pharmacovigilance, medical affairs, health economics and quality/Gmp and the wider healthcare community.
It’s a great networking opportunity with delegates coming from a wide cross-section of the industry including senior executives to recent graduates. In 2019, over 2200 day delegates visited the conference.
Please feel free to drop by the Bellberry exhibit, we look forward to seeing you!
Breakthroughs in prostate cancer screening and a ‘watch and wait’ treatment for collapsed lung share the Australian Clinical Trials Alliance 2021 Trial of the Year Award The Australian Clinical Trials Alliance (ACTA) is pleased to announce dual winners of their preeminent 2021 ACTA Trial of the Year Award. This event celebrates the vital role trials have in advancing clinical practice and saving or improving patients’ lives every year. The dual winners of the 2021 Trial of the Year Award are:- ProPSMA Prostate-specific membrane antigen PET-CT in patients with high-risk prostate cancer before curative-intent surgery or radiotherapy (ProPSMA): a prospective, randomised, multicentre study.
- Pneumothorax study A randomised controlled trial of conservative versus interventional treatment for spontaneous pneumothorax.
AusMedtech 2021: Reimagine and reconnect provides a week of virtual half-day sessions that represent Australia’s medtech industry; celebrate the successes and impacts the industry has made, and engage on the reimagined future of medtech.
Kylie Sproston, Bellberry CEO, will be part of a panel discussion being held on Tues 18 May titled ‘Lessons learnt: Clinical trials, ethics and governance, regulatory approvals and the new normal’
AusMedtech week will be delivered online
The AAHRPP annual conference will take place from May 18 to May 20. Join Kylie Sproston, Bellberry CEO, and Dr. Amal Al Omari, Speakers Chief Scientific Officer King, Hussein Cancer Center at their session on May 20 entitled ‘International Research – Collaboration During Crisis’
Join ACTA in honouring the remarkable Australians who advance our health system by designing, conducting, or participating in ground-breaking clinical trials and promote the importance of clinical trials and the expertise and complexity of the work involved.
This collaborative event will recognise the achievements of the research sector, with awards for the ACTA Trial of the Year, ACTA STInG Excellence in Trial Statistics, and the ACTA Consumer Involvement. The Award Ceremony will be preceded by the launch of the ‘Clinical Trials in Australia’ report and a panel session hosted by MTPConnect.
A networking reception will follow the Award Ceremony with drinks and canapes and the much-needed opportunity to connect with colleagues. Registration is essential and seats are limited.
2021 National Tribute and Award Ceremony Invitation
Sometimes it is difficult to put feelings into words. They say a picture can tell a thousand words, so the White Coats Foundation is inviting you to express ‘Your Voice’ by creating a picture, painting, symbol or sending in a photo that represents what clinical trials mean to you.
Perhaps you are a patient that has benefited from participating in a clinical trial or a recipient of an approved medication that is available because of a clinical trial or a health care professional who supports patients on clinical trials or an industry professional who is witness to the impact that medical advances can bring to people’s lives. Whatever your circumstances, the White Coats Foundation want to hear your voice and see your story.
Submission open between 6 April and 3 May
The White Coats Foundation will select a shortlist of entries for further presentation at the White Coats Foundation “Your Voice, Your Story ” public webinar to be held on International Clinical Trials Day-20th of May.
Learn more here: https://whitecoatsfoundation.org/your-voice/
AusBiotech invites you to its virtual showcase highlighting Australia’s clinical trial and medical innovation advantages, coinciding with the annual JP Morgan and Biotech Showcase week in January 2021. This virtual event will be hosted in Melbourne on Fri 15 Jan, 10-11.35am (AEDT).
Australia has been amongst the globe’s lesser COVID-19-impacted countries, providing the opportunity to start and continue clinical trials and medical research through the pandemic. Through careful management of the pandemic, clinical trials are not only giving Australian patients access to new therapies, vaccines and medical devices, but also giving the country a comparative advantage as a destination for clinical trials from around the globe.
Working in Australia offers a compelling opportunity for clinical trials, with robust regulation, access to established and proven pathways of obtaining high quality clinical data recognised by US and European regulators, and other global institutions.
Bellberry CEO Kylie Sproston will be speaking at this event. Click HERE TO REGISTER
The ACTA Summit 2020 will be a ‘virtual’ gathering of Australian and international experts to discuss the design and conduct of clinical trials, developments in clinical quality registries, embedding research into healthcare, new approaches to practice, and innovations in clinical trial governance and consumer engagement.
Bellberry is proud to be a gold sponsor for this event and Bellberry CEO Kylie Sproston will be speaking at a session on Weds 2 December entitled ‘Responses to COVID-19: the Broader Perspective’
The Clinical Trials 2020: National Tribute and Award Ceremony will also be presented during the Summit. We look forward to seeing you there!